You are here: Industry Insights > COVID-19 Vaccine

News List

Moderna to get additional $472m from BARDA for Covid-19 vaccine pharmaceutical-technology
July 28, 2020
Moderna and the US Biomedical Advanced Research and Development Authority (BARDA) have updated their contract for an additional funding commitment of up to $472m.
SGS Signs Analytical Testing Agreement with AstraZeneca contractpharma
July 28, 2020
Will provide safety, quality control and analytical testing services in support of a COVID-19 vaccine candidate AZD1222.
Five sites in India ready for Oxford-AstraZeneca COVID-19 vaccine trial: DBT expresspharma
July 28, 2020
The vaccine is in its third phase of human trials, Serum Institute of India is partnering Oxford and AstraZeneca to manufacture the vaccine once it is ready.
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate expresspharma
July 28, 2020
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US.
Gov unveils plans to boost UK's vaccines manufacturing capabilities pharmatimes
July 27, 2020
The government is streaming an additional £100 million into ensuring that any COVID-19 vaccine making it to the finish line can be produced at scale in the UK.
Arcturus agrees to supply potential Covid-19 vaccine to Israel pharmaceutical-technology
July 27, 2020
US-based mRNA medicines company Arcturus Therapeutics has signed a binding term sheet with the Israeli Ministry of Health to supply its potential Covid-19 vaccine, LUNAR-COV19.
Dynavax and Medigen partner to develop adjuvanted Covid-19 vaccine pharmaceutical-technology
July 27, 2020
US-based Dynavax Technologies has partnered with Taiwan, China-based Medigen Vaccine Biologics to develop an adjuvanted Covid-19 vaccine candidate.
US sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot expresspharma
July 27, 2020
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to be safe and effective in a large pivotal clinical trial expected to start this month.
UK pledges 100 million pounds to scale up COVID-19 vaccine production expresspharma
July 27, 2020
Britain said it will provide 100 million pounds ($127 million) of funding for a facility to scale up the manufacturing of vaccines for COVID-19.
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate expresspharma
July 27, 2020
DBT-BIRAC has facilitated the establishment of ‘first-of-its-kind’ mRNA-based vaccine manufacturing platform in India. It has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page